Psychiatric Comorbidity and Quality of Life in Patients With Obsessive Compulsive Disorder(Case Control Study )
NCT ID: NCT05105581
Last Updated: 2021-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
37 participants
OBSERVATIONAL
2021-11-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Treatment may involve psychotherapy, such as cognitive behavioral therapy (CBT), and antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) or clomipramine.\[4\]\[5\] CBT for OCD involves increasing exposure to fears and obsessions while preventing the compulsive behavior that would normally accompany the obsessions.\[4\] Contrary to this, metacognitive therapy encourages the ritual behaviors in order to alter the relationship to one's thoughts about them.\[9\] While clomipramine appears to work as well as do SSRIs, it has greater side effects and thus is typically reserved as a second-line treatment.\[4\] Atypical antipsychotics may be useful when used in addition to an SSRI in treatment-resistant cases but are also associated with an increased risk of side effects.\[5\]\[10\] Without treatment, the condition often lasts decades.\[2\]
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (Patients)
Patients: 37 patients with OCD diagnosed according to DSM-5
1. Inclusion criteria:
1. both sex
2. age groups : 18 : 60 are included
3. accept to participate in the study
2. Exclusion criteria
1. presence of major neurological disease as head trauma and sensory or motor defect as blindness or deafness
2. Active psychiatric disordes
3. patients refuse to participate in the study
No interventions assigned to this group
Group 2 (Controlled)
37 healthy populations matched with PT group in age , sex , socioeconomic state
Quality of life scale
1. To assess the quality of life of patient
2. To assess the degree of OCD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of life scale
1. To assess the quality of life of patient
2. To assess the degree of OCD
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2\. Active psychiatric disordes 3. patients refuse to participate in the study
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Safwat AbdElrhman
Assistant Professor of Psychiatry
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Assiut Unirvesity Hospital
Identifier Type: -
Identifier Source: org_study_id